v3.26.1
Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Share Capital [Member]
Reverse recapitalization reserve [member]
Merger reserve [member]
Reserve of share-based payments [member]
Statutory reserve [member]
Capital reserve [member]
Retained earnings [member]
Reserve of exchange differences on translation [member]
Equity attributable to owners of parent [member]
Non-controlling interests [member]
Total equity [member]
Beginning balance, value at Sep. 30, 2024 $ 130,300 $ (79,596) $ 9,257 $ 32,786 $ 21,238 $ 9,614 $ (106,599) $ 2,564 $ 19,564 $ 438 $ 20,002
IfrsStatementLineItems [Line Items]                      
Net income (loss) for the period (4,131) (4,131) 337 (3,794)
Exchange difference on transaction of financial statements of foreign operations (563) (563) (16) (579)
Total comprehensive loss for the period (4,131) (563) (4,694) 321 (4,373)
Conversion of long-term notes into common shares 2,901 2,901 2,901
Equity compensation - employee share-based compensation 758 758 758
Issuance of new shares for equity financing 6,760 6,760 6,760
Ending balance, value at Mar. 31, 2025 139,961 (79,596) 9,257 33,544 21,238 9,614 (110,730) 2,001 25,289 759 26,048
Beginning balance, value at Sep. 30, 2025 149,053 (79,596) 9,257 35,399 21,238 9,614 (119,400) 1,092 26,657 236 26,893
IfrsStatementLineItems [Line Items]                      
Net income (loss) for the period (3,327) (3,327) 736 (2,591)
Exchange difference on transaction of financial statements of foreign operations 668 668 16 684
Total comprehensive loss for the period (3,327) 668 (2,659) 752 (1,907)
Shares issued for paying off interest payable 1,881 1,881 1,881
Conversion of long-term notes into common shares 1,401 1,401 1,401
Equity compensation - employee share-based compensation 2,691 2,691 2,691
Ending balance, value at Mar. 31, 2026 $ 152,335 $ (79,596) $ 9,257 $ 38,090 $ 21,238 $ 9,614 $ (122,727) $ 1,760 $ 29,971 $ 988 $ 30,959